Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
|
|
Agence France Presse (11.02.09) - Tuesday, November 03, 2009
HR 3974, whose short title is the "Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009," was introduced by Rep. Mike Honda (D-Calif.). It would fund the fight through appropriations of $90 million in fiscal years 2010 and 2011, $110 million in FY 2012, $130 million in FY 2013 and $150 million in FY 2014. The bill's 11 cosponsors include four Republicans.
Rep. Bill Cassidy (R-La.), a physician, is a cosponsor. "As a hepatologist, I have witnessed firsthand the consequences hepatitis can inflict on a patient's health, their families and the nation's health care budget," he said.
Honda contends the nation's fight against hepatitis is underfunded: He points out that just $18.3 million is allocated to combat hepatitis in FY 2009, compared to $692 million for domestic HIV-fighting efforts.
"We have a wave of chronic liver disease that will crash like a tsunami on the United States health care system if we do not address this problem now," said Lorren Sandt, chair of the National Viral Hepatitis Roundtable. "This simple legislation will help identify the people who are chronically infected and get them into treatment, which can save millions in future health care costs."
CDC says 5 million US residents are infected with hepatitis B or C and many are unaware they carry the viruses.
The legislation was referred to the House Energy and Commerce Committee. Honda, who leads the Asian-American caucus in Congress, continues to seek additional supporters.
091103
AD091884
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.